Developing a predictive model for baseline detection and follow-up of risk of prostate cancer progression on active surveillance
Prostate cancer is the most common cancer in men in 112 countries, and its incidence and mortality will have doubled by 2040. Nearly 50% of newly presenting patients in the UK harbour low and intermediate-favourable-risk localised disease, for which active surveillance (AS) offers non-inferior survival outcomes compared to radical treatment. AS involves repeat testing to […]
Dr Nikita Sushentsev
Emmanuel College, University of Cambridge